Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Nov 6;10(11):3056.
doi: 10.3390/cells10113056.

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis

Affiliations
Review

The Increasing Role of Kappa Free Light Chains in the Diagnosis of Multiple Sclerosis

Franz Felix Konen et al. Cells. .

Abstract

Free light chains (FLC) are a promising biomarker to detect intrathecal inflammation in patients with inflammatory central nervous system (CNS) diseases, including multiple sclerosis (MS). The diagnostic use of this biomarker, in particular the kappa isoform of FLC ("KFLC"), has been investigated for more than 40 years. Based on an extensive literature review, we found that an agreement on the correct method for evaluating KFLC concentrations has not yet been reached. KFLC indices with varying cut-off values and blood-CSF-barrier (QAlbumin) related non-linear formulas for KFLC interpretation have been investigated in several studies. All approaches revealed high diagnostic sensitivity and specificity compared with the oligoclonal bands, which are considered the gold standard for the detection of intrathecally synthesized immunoglobulins. Measurement of KFLC is fully automated, rater-independent, and has been shown to be stable against most pre-analytic influencing factors. In conclusion, the determination of KFLC represents a promising diagnostic approach to show intrathecal inflammation in neuroinflammatory diseases. Multicenter studies are needed to show the diagnostic sensitivity and specificity of KFLC in MS by using the latest McDonald criteria and appropriate, as well as standardized, cut-off values for KFLC concentrations, preferably considering non-linear formulas such as Reiber's diagram.

Keywords: biomarker; cerebrospinal fluid; kappa free light chains; multiple sclerosis; review; serum.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest. H.T. reports funding for research projects, lectures, and travel from Alexion, Bayer, Biogen, Celgene, Genzyme-Sanofi, Merck, Novartis, Roche, Teva, and received research support from DMSG and BMBF.

References

    1. Bollengier F., Lowenthal A., Henrotin W. Bound and free light chains in subacute sclerosing panencephalitis and multiple sclerosis serum and cerebrospinal fluid. Z. Klin. Chem. Klin. Biochem. 1975;13:305–310. doi: 10.1515/cclm.1975.13.7.305. - DOI - PubMed
    1. Solomon A. Bence-Jones proteins and light chains of immunoglobulins (second of two parts) N. Engl. J. Med. 1976;294:91–98. doi: 10.1056/NEJM197601082940206. - DOI - PubMed
    1. Kaplan B., Livneh A., Sela B.A. Immunoglobulin free light chain dimers in human diseases. TheScientificWorldJournal. 2011;11:726–735. doi: 10.1100/tsw.2011.65. - DOI - PMC - PubMed
    1. Stendahl-Brodin L., Link H. Relation between benign course of multiple sclerosis and low-grade humoral immune response in cerebrospinal fluid. J. Neurol. Neurosurg. Psychiatry. 1980;43:102–105. doi: 10.1136/jnnp.43.2.102. - DOI - PMC - PubMed
    1. Reich D.S., Lucchinetti C.F., Calabresi P.A. Multiple Sclerosis. N. Engl. J. Med. 2018;378:169–180. doi: 10.1056/NEJMra1401483. - DOI - PMC - PubMed

Publication types

MeSH terms